JNJ's Dividend Streak Faces Test as PG Maintains Productivity Shield

Johnson & Johnson's (JNJ) forward annualized dividend of $5.36 tops Procter & Gamble's (PG) $4.354, but a planned mid-2027 DePuy Synthes spinoff puts J&J's long streak at risk.

P&G CEO Shailesh Jejurikar committed $10 billion in dividends and $5 billion in buybacks for fiscal 2027, shielded by $2.8 billion in productivity savings.

JNJ's stock surged 28.5% YTD versus PG's 1.3% gain, driven by pipeline strength across 28 billion-dollar platforms, not payout policy.

P&G has no such event planned and its dividend streak is intact, with a generous coverage ratio and productivity funding the raise.